Vericel (VCEL) Assets Average (2011 - 2026)
Vericel (VCEL) reported Assets Average of $486.8 million for Q1 2026, up 13.56% on a YoY basis from $428.7 million in Q1 2025, and up 3.44% sequentially from $470.6 million in Q4 2025.
Vericel (VCEL) Assets Average (2011 - 2026) Analysis & Trends
Vericel (VCEL) has 16 years of Assets Average data on file, last reported at $486.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 13.56% year-over-year to $486.8 million; the trailing twelve-month figure through Mar 2026 stood at $486.8 million (up 13.56% YoY), and the FY2025 full-year result was $460.3 million, up 17.08% from the prior year.
- Assets Average grew to $486.8 million in Q1 2026, from $470.6 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $486.8 million in Q1 2026 to a low of $242.0 million in Q1 2022.
- A 5-year average of $351.6 million and a median of $355.2 million in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average gained 10.48% in 2022 and surged 32.01% in 2024, its largest moves.
- Tracing VCEL's Assets Average over 5 years: stood at $260.5 million in 2022, then rose by 28.94% to $335.9 million in 2023, then grew by 22.53% to $411.6 million in 2024, then gained by 14.35% to $470.6 million in 2025, then grew by 3.44% to $486.8 million in 2026.
- Business Quant data shows VCEL's Assets Average at $486.8 million in Q1 2026, $470.6 million in Q4 2025, and $444.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 486.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 486.80 Mn |
| Dec 31, 2025 | 470.62 Mn |
| Sep 30, 2025 | 444.44 Mn |
| Jun 30, 2025 | 430.10 Mn |
| Mar 31, 2025 | 428.65 Mn |
| Dec 31, 2024 | 411.56 Mn |
| Sep 30, 2024 | 383.62 Mn |
| Jun 30, 2024 | 366.75 Mn |
| Mar 31, 2024 | 355.16 Mn |
| Dec 31, 2023 | 335.89 Mn |
| Sep 30, 2023 | 314.42 Mn |
| Jun 30, 2023 | 287.90 Mn |
| Mar 31, 2023 | 269.05 Mn |
| Dec 31, 2022 | 260.51 Mn |
| Sep 30, 2022 | 246.42 Mn |
| Jun 30, 2022 | 242.55 Mn |
| Mar 31, 2022 | 242.00 Mn |
| Dec 31, 2021 | 233.92 Mn |
| Sep 30, 2021 | 223.04 Mn |
| Jun 30, 2021 | 216.70 Mn |